Sort by 'likes'
Will Modern Therapies Replace Auto and Allo Transplants in Myeloma Treatment?
In just the past 2 months, 3 new drugs for myeloma treatment have been approved by the FDA. In addition to this, there are many more drugs currently undergoing clinical trials. With so many more options for immunotherapy drugs coming…
Myeloma with MD Anderson’s Dr. Orlowski
Shoot for a 100% complete response is what doctors are aiming for and this may soon become a reality with new drug combinations which are showing a lot of promise, informs Dr. Orlowksi. Newly diagnosed patients to high-risk patients, Dr.…
Immunotherapy Advances in Multiple Myeloma
Recent years have seen the emergence of immunotherapy as a leading form of treatment for multiple myeloma. New strategies such as monoclonal antibody therapies. antibody-drug conjugates, immune checkpoint therapy, adoptive cell therapies such as natural killer cells, marrow infiltrating lymphocytes,…
Transplants and Risk Adapted Maintenance in Myeloma Treatment
The treatment paradigm for myeloma patients has changed in the last decade with important advancements such as proteasome inhibitors, IMiDS, antibodies and risk-adapted maintenance. How a patient responds to therapy can be used to determine how long the maintenance or…
What is Fibrodysplasia Ossificans Progressiva (FOP)? Exploring the Rare Genetic Disorder with Leading Experts
Fibrodysplasia ossificans progressiva (FOP) is an ultra rare disease, where soft tissues progressively turn into bone. FOP affects approximately 1 in 2 million people worldwide. This condition is caused by a mutation in the ACVR1 gene, which disrupts the body’s…